HbA1c Analyzers Market 2022 Global Analysis, Opportunities and Forecast to 2028

Persistence Market Research (PMR)’s most recent study projects that North America will dominate the Global HbA1c Analyzers Market. According to the research, the Global HbA1c Analyzers Market will exceed US$ 2,664.3 Mn by 2028, at a CAGR of 5.4%. Diabetes’ rising prevalence is a major driver of HbA1c sales globally. The growing elderly population, as well as the various advantages of HbA1c analyzers, are likely to drive the growth of the HbA1c analyzers market.

According to the International Diabetes Federation, around 463 million people were diagnosed with diabetes in 2019, the figure is expected to rise to 700 million by 2045. Increasing alcohol consumption, unhealthy dietary habits, less physical activity, smoking, and stress have all contributed to an increase in the prevalence of diabetes and other related diseases.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/29293

hbac-analyzers-market

Companies

  • Abbott
  • ApexBio
  • ARKRAY, Inc.
  • Bio-Rad Laboratories, Inc.
  • Convergent Technologies GmbH & Co. KG
  • EKF Diagnostics
  • Erba Mannheim
  • F. Hoffmann-La Roche Ltd
  • HemoCue AB
  • i-SENS, Inc.
  • labONE, Inc.
  • LITE-ON TECHNOLOGY CORPORATION
  • Meril Life Sciences Pvt. Ltd.
  • OSANG Healthcare
  • TaiDoc Technology Corporation
  • Tosoh Corporation
  • Trinity Biotech
  • Zivak Technologies USA

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/29293

North America to Dominate Global HbA1c Analyzers Market

North America is expected to lead the global portable HbA1c analyzers market during the forecast period, due to an increase in the number of diabetic patients in countries such as the US. One of the primary macroeconomic factors driving the growth of the HbA1c analyzers market in this region is the rising per capita healthcare expenditure.

Apart from that, favorable government regulations and reimbursement has increased healthcare awareness, and increased usage of HbA1c analyzers is are likely to fuel the growth of the HaAc analyzers market.

Europe, following North America, is likely to have a fairly significant revenue share in the global HbA1c analyzers market.

The Impact of COVID-19 on the Global HbA1c Analyzers Market

COVID-19 had an impact on almost every industry, and its emergence in 2020 had resulted in a significant decrease in HbA1c testing volume and sales. However, it was a temporary setback and the testing volume and sales increased in 2021 when the situation improved and the Covid-19 restrictions were removed.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/29293

Want More Insights?

PMR has presented a comprehensive report based on HbA1c Analyzers as per Technology (High-performance Liquid Chromatography (HPLC), Ion Exchange Chromatography, Boronate Affinity Technology, and Boronate Affinity HPLC), End User (Hospitals, Specialty Clinics, Diagnostic Centers, and Others), based on seven regions.

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]